Champions Oncology (CSBR) EBITDA Margin Growth (5y) (2015 - 2026)
Champions Oncology (CSBR) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Champions Oncology | 71.17 Mn | 71.17 Mn | 7.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 236.00 |
| Jan 31, 2026 | -1,075.00 |
| Oct 31, 2025 | 116.00 |
| Jul 31, 2025 | -402.00 |
| Apr 30, 2025 | 696.00 |
| Jan 31, 2025 | 2,160.00 |
| Oct 31, 2024 | 161.00 |
| Jul 31, 2024 | 1,857.00 |
| Apr 30, 2024 | -43.00 |
| Jan 31, 2024 | -1,569.00 |
| Oct 31, 2023 | -2,100.00 |
| Jul 31, 2023 | -2,804.00 |
| Apr 30, 2023 | -712.00 |
| Jan 31, 2023 | -1,793.00 |
| Oct 31, 2022 | 139.00 |
| Jul 31, 2022 | 1,023.00 |
| Apr 30, 2022 | 6,181.00 |
| Jan 31, 2022 | 4,559.00 |
| Oct 31, 2021 | 1,329.00 |
| Jul 31, 2021 | 6,719.00 |